Mass General Brigham’s Tango Therapeutics TNGX Stock Holding History
Bought
Maintained
Sold
Other funds holding TNGX
SL
Mass General Brigham's TNGX Position: Q3 2026 in Review
Mass General Brigham held its Tango Therapeutics (TNGX) position steady in Q3 2026 at 354,192 shares worth $8.84M. The position accounts for 1.94% of the portfolio, ranked #5.
Mass General Brigham first reported a position in TNGX in Q1 2024 and has held it in 7 quarters since. The position peaked at $11.1M in Q2 2026. 257 funds tracked by Wall St. Rank hold TNGX as of Q3 2026.
- Mass General Brigham held 354,192 shares of Tango Therapeutics worth $8.84M as of Q3 2026.
- Mass General Brigham left its Tango Therapeutics share count unchanged in Q3 2026.
- Tango Therapeutics made up 1.94% of Mass General Brigham's portfolio in Q3 2026, its #5 holding.
- Mass General Brigham first reported a position in Tango Therapeutics in Q1 2024 and has held it in 7 quarters since.
- Mass General Brigham's Tango Therapeutics position peaked at $11.1M in Q2 2026.
- 257 funds tracked by Wall St. Rank held Tango Therapeutics as of Q3 2026.
Based on Mass General Brigham's 13F filing for Q3 2026, filed 3 Nov 2026.